Article Text

Download PDFPDF
Non-inherited maternal human leukocyte antigen alleles in susceptibility to familial rheumatoid arthritis
  1. K A Guthrie1,
  2. N R Tishkevich2,
  3. J L Nelson2,3
  1. 1
    Clinical Statistics, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
  2. 2
    Department of Medicine, Rheumatology, University of Washington, Seattle, Washington, USA
  3. 3
    Immunogenetics, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
  1. K A Guthrie, Clinical Statistics D5-360, Fred Hutchinson Cancer Research Center 1100 Fairview Ave. N, Seattle, Washington 98109-1024, USA; kguthrie{at}fhcrc.org

Abstract

Objectives: Some patients with rheumatoid arthritis (RA) lack RA-associated human leukocyte antigen (HLA) alleles. Prior studies investigated non-inherited maternal HLA alleles (NIMA) in RA risk with conflicting results.

Methods: We examined NIMA in a large cohort of families from the North American Rheumatoid Arthritis Consortium (NARAC).

Results: Among 620 patients with 1 or both parents having a HLA genotype, patients with RA informative for analysis included 176 without HLA-DRB1*04 and 86 without the HLA shared epitope (SE). The frequency of NIMA encoding HLA-DR4 or the SE was compared to the non-inherited paternal allele (NIPA). DR4-encoding NIMA vs NIPA revealed no significant difference (27% vs 20%). However, parity is known to modulate RA risk and analyses stratified by sex and age of onset showed significant variation among women. Interestingly, among women with onset <45 years DR4-encoding NIMA was increased compared to NIPA; among women ⩾45 years at onset the reverse was observed (31% vs 16% compared to 10% vs 60%, p = 0.008). DR4 encoding NIMA vs NIPA did not differ in men. The SE did not differ in men or women.

Conclusions: Risk of RA was associated with HLA-DR4 encoding NIMA in younger-onset women but not in older-onset women or men. These observations could help explain conflicting prior results of NIMA in RA.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests: None declared.

  • Funding: This study was supported by US National Institutes of Health grants NO1 AR22263, AI45659 and AI41721.

  • Ethics approval: Ethics approval was obtained.